Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)
| 145.61 BATS BZX Real-Time Price As of 1:05pm ET |  +3.42 / +2.41%Today’s Change | 117.58 Today|||52-Week Range 212.00 | -14.13% Year-to-Date |
Institutional investors hold a majority ownership of ALNY through the 95.53% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2019, these large investors purchased a net $2.9 million shares.
| Mutual fund holders | 63.12% |
| Other institutional | 32.41% |
| Individual stakeholders | 18.39% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 3/31/2022 | CAPITAL RESEARCH & MANAGEMENT CO... Bought 5.7 Million shares of Alnylam Pharmaceuticals I... |
| 3/31/2022 | AMUNDI ASSET MANAGEMENT US, INC. Bought 583.6 Thousand shares of Alnylam Pharmaceuticals I... |
| 3/31/2022 | DEEP TRACK CAPITAL LP Bought 463.7 Thousand shares of Alnylam Pharmaceuticals I... |
Top 10 Owners of Alnylam Pharmaceuticals Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Fidelity Management & Research Co... | 12.86% | 15,536,134 | 1,954,445,657 | -2,002,617 | -11.42% |
| The Vanguard Group, Inc. | 8.76% | 10,581,970 | 1,331,211,826 | +140,110 | +1.34% |
| Baillie Gifford & Co. | 8.39% | 10,139,729 | 1,275,577,908 | -477,022 | -4.49% |
| Wellington Management Co. LLP | 5.82% | 7,034,487 | 884,938,465 | +190,057 | +2.78% |
| T. Rowe Price Associates, Inc. (I... | 5.62% | 6,794,166 | 854,706,083 | +258,798 | +3.96% |
| Capital Research & Management Co.... | 4.97% | 5,999,674 | 754,758,989 | +5,680,728 | +1,781.09% |
| Dodge & Cox | 4.53% | 5,475,668 | 688,839,034 | +44,600 | +0.82% |
| BlackRock Fund Advisors | 4.46% | 5,385,918 | 677,548,484 | +124,312 | +2.36% |
| SSgA Funds Management, Inc. | 2.41% | 2,909,490 | 366,013,842 | +59,101 | +2.07% |
| JPMorgan Investment Management, I... | 1.82% | 2,193,153 | 275,898,647 | -20,974 | -0.95% |
Top 10 Mutual Funds Holding Alnylam Pharmaceuticals Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Vanguard Health Care Fund | 4.29% | 5,187,603 | 652,600,457 | -1,122,424 | -17.79% |
| Vanguard Total Stock Market Index... | 2.92% | 3,532,713 | 444,415,295 | +47,640 | +1.37% |
| Dodge & Cox Stock Fund | 2.69% | 3,249,177 | 408,746,467 | 0 | 0.00% |
| American Funds Growth Fund of Ame... | 2.63% | 3,182,456 | 400,352,965 | +3,002,900 | +1,672.40% |
| Vanguard Mid Cap Index Fund | 2.27% | 2,738,390 | 344,489,462 | +5,367 | +0.20% |
| Fidelity Growth Company Fund | 2.25% | 2,718,031 | 341,928,300 | -278,973 | -9.31% |
| Vanguard Extended Market Index Fu... | 1.33% | 1,601,443 | 201,461,529 | +5,734 | +0.36% |
| T Rowe Price Mid Cap Growth Fund | 1.28% | 1,548,000 | 194,738,400 | -2,000 | -0.13% |
| T Rowe Price New Horizons Fund | 1.20% | 1,449,940 | 182,402,452 | +124,500 | +9.39% |
| Fidelity OTC Portfolio | 1.18% | 1,424,030 | 179,142,974 | -720 | -0.05% |